Insmed Incorporated Provides Sales Guidance for the Full Year 2023 and 2024
The company anticipates 2024 global ARIKAYCE revenues to be between $340 million and $360 million, representing 15% year-over-year growth at the midpoint compared to 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.95 USD | +1.57% | +3.80% | -16.26% |
1st Jan change | Capi. | |
---|---|---|
-16.26% | 3.86B | |
+9.15% | 106B | |
-1.08% | 104B | |
+7.57% | 23.25B | |
-11.55% | 22.5B | |
-7.19% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |